Below are the most recent publications written about "Partial Thromboplastin Time" by people in Profiles.
-
Prucnal CK, Jansson PS, Deadmon E, Rosovsky RP, Zheng H, Kabrhel C. Analysis of Partial Thromboplastin Times in Patients With Pulmonary Embolism During the First 48 Hours of Anticoagulation With Unfractionated Heparin. Acad Emerg Med. 2020 02; 27(2):117-127.
-
Georgi B, Mielke J, Chaffin M, Khera AV, Gelis L, Mundl H, van Giezen JJJ, Ellinor P, Kathiresan S, Ziegelbauer K, Freitag DF. Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI. Stroke. 2019 11; 50(11):3004-3012.
-
Musson EN, Lomas O, Murphy MF. Acute thrombocytopenia: picking a way through a paucity of platelets. Br J Hosp Med (Lond). 2019 Sep 02; 80(9):507-512.
-
Dasenbrock HH, Smith TR, Robinson S. Preoperative laboratory testing before pediatric neurosurgery: an NSQIP-Pediatrics analysis. J Neurosurg Pediatr. 2019 04 12; 24(1):92-103.
-
Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 06; 209:212-219.e1.
-
Villalba JA, Van Cott EM. High frequency of false-positive results of aPTT-based lupus anticoagulant tests in patients receiving argatroban. Am J Hematol. 2019 06; 94(6):E166-E169.
-
McLaughlin K, Rimsans J, Sylvester KW, Fanikos J, Dorfman DM, Senna P, Connors JM, Goldhaber SZ. Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619876030.
-
Waack U, Warnock M, Yee A, Huttinger Z, Smith S, Kumar A, Deroux A, Ginsburg D, Mobley HLT, Lawrence DA, Sandkvist M. CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII. mBio. 2018 12 18; 9(6).
-
Silvain J, O'Connor SA, Yan Y, Kerneis M, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ankri A, Brugier D, Vicaut E, Ecollan P, Galier S, Collet JP, Montalescot G. Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin. Am J Cardiovasc Drugs. 2018 Dec; 18(6):503-511.
-
Zavlin D, Chegireddy V, Jubbal KT, Agrawal NA, Spiegel AJ. Management of Microsurgical Patients using Intraoperative Unfractionated Heparin and Thromboelastography. J Reconstr Microsurg. 2019 Mar; 35(3):198-208.